Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement. (2023)
Attributed to:
Clonal heterogeneity and therapy resistance in Burkitt lymphoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2021.280557
PubMed Identifier: 35484682
Publication URI: http://europepmc.org/abstract/MED/35484682
Type: Journal Article/Review
Volume: 108
Parent Publication: Haematologica
Issue: 3
ISSN: 0390-6078